Disclosure: Some links on this site are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you. Thank you for supporting our site.·For informational purposes only—not medical advice.
Fact-checked against primary sources: FDA.gov prescribing information, published clinical trial data (NEJM, Nature Medicine, JAMA Network Open), provider terms of service, Trustpilot, and ConsumerAffairs.
MEDVi vs Ozempic: Which One Actually Makes Sense for Weight Loss?
You searched MEDVi vs Ozempic because you saw the price difference and thought: Is this real? Is it safe? Am I getting the same thing?
Here's the short answer so you don't have to scroll: MEDVi is not Ozempic. Ozempic is a brand-name FDA-approved medication made by Novo Nordisk. MEDVi is a telehealth program that may prescribe compounded GLP-1 medications. Compounded GLP-1 drugs are not FDA-approved, and the FDA has warned that marketing them as “the same as” FDA-approved products can be misleading. They are different products with different regulatory pathways — but both involve semaglutide-based treatment under physician supervision.
The cost difference? Ozempic now runs $349–$499/month through Novo Nordisk's self-pay program (with a limited-time $199 intro offer on lowest doses). MEDVi starts at $179/month and includes your consultation, medication, and shipping. Understanding exactly what each option gives you — and what it doesn't — is the entire point of this page. For broader context, see our GLP-1s for weight loss guide and GLP-1 cost breakdown.
Quick Decision Guide
- If your insurance covers Ozempic or Wegovy → use your insurance. That's the best deal.
- If you're paying cash and want the FDA-approved product → Novo Nordisk's self-pay program starts at $349/mo.
- If you want a lower-cost, physician-supervised GLP-1 program → MEDVi starts at $179/mo.
MEDVi vs Ozempic: verified pricing and safety comparison for 2026.
*Illustration only. Actual medication packaging and appearance may vary.*
MEDVi vs Ozempic at a Glance
Pricing and policies verified directly from medvi.org and ozempic.com on March 30, 2026. For a deeper look at how compounded semaglutide safety works, see our dedicated guide.
| Category | MEDVi | Ozempic |
|---|---|---|
| What it is | Telehealth platform; compounded semaglutide is the core path. Also offers branded Wegovy pill, Wegovy injection, and Zepbound injection via separate $99/mo membership. | Brand-name prescription medication |
| Active ingredient | Compounded semaglutide on the core path (not FDA-approved as a finished product); branded Wegovy or Zepbound available via $99/mo membership path | Semaglutide (brand, by Novo Nordisk) |
| FDA status | Compounded medications are not FDA-approved. Prepared by pharmacies under state licensing. | FDA-approved for type 2 diabetes (2017). Not FDA-approved for weight loss — that's Wegovy. |
| Typical use | Weight loss (cash-pay patients) | Type 2 diabetes; off-label for weight loss |
| First month cost | $179 (injections) / $249 (tablets) | $199 intro offer (0.25/0.5mg doses through June 30, 2026) |
| Ongoing monthly cost | $299 (injections) / $369 (tablets) | $349/mo (≤1mg) or $499/mo (2mg) via NovoCare self-pay |
| Annual cost (cash-pay) | ~$3,468 first year | ~$4,188–$5,988 first year (NovoCare) |
| Insurance accepted | No — cash-pay only | Yes, for type 2 diabetes. Rarely covered for weight loss alone. |
| What's included | Physician review, medication, personalized plan, 24/7 support, shipping | Medication only (doctor visits, pharmacy trips separate) |
| Medication format | Weekly injections OR daily dissolvable tablets | Weekly injection pen only |
| Medical oversight | U.S.-licensed clinicians via telehealth (OpenLoop Health network) | Your prescribing doctor (in-person or telehealth) |
| Pharmacy partners | U.S. licensed compounding pharmacies (Belmar Pharma Solutions among partners) | Novo Nordisk FDA-inspected manufacturing |
| Shipping | Direct to door, temperature-controlled, 5–9 days | NovoCare home delivery or pharmacy pickup |
| Contract / Billing | Month-to-month subscription. Cancellation request must be received 72+ hours before billing date or the next charge still runs. No cancellation fee. | N/A (standard prescription) |
| Available states | 49 states | All 50 states |
| Guarantee | Refund if medically disqualified from program. Ordinary cancellation of subscription services does not trigger a refund per current published policy. | No guarantee |
| Third-party ratings | 4.4/5 TrustScore on Trustpilot (11,498 reviews; March 30, 2026); LegitScript certified | N/A (pharmaceutical product, not a service) |
Source: MEDVi pricing from medvi.org. Ozempic pricing from ozempic.com and novocare.com. Clinical data from peer-reviewed trials cited in our sources section.
Who Should Pick MEDVi, Who Should Pick Ozempic, and Who Should Wait
Not every option is right for every person. Here's how to decide in 60 seconds.
Pick Ozempic if…
- Your insurance covers it. If you have type 2 diabetes and your plan covers Ozempic, your copay could be as low as $25/month. That's unbeatable.
- You specifically need an FDA-approved finished product. Some people want the confidence that comes with FDA-approved manufacturing from start to finish.
- Your doctor already prescribed it. If you have a relationship with an endocrinologist or primary care doctor managing your treatment, stay the course.
- You have type 2 diabetes. Ozempic is FDA-approved specifically for this. Your doctor should be leading this decision.
Pick MEDVi if…
- You're paying out of pocket and budget matters. MEDVi's $179–$299/month is meaningfully less than Ozempic's $349–$499 NovoCare self-pay price.
- You can't get a prescription easily. No long wait for appointments. No insurance denials. No prior authorization headaches.
- You want a structured program, not just a prescription. MEDVi includes 24/7 messaging support, dose adjustments, coaching, and check-ins.
- You want a needle-free option. MEDVi offers daily dissolvable semaglutide tablets starting at $249/month. Ozempic is injection-only.
- You understand compounded medications. You know you're getting medication from a licensed compounding pharmacy, not from Novo Nordisk. You're comfortable with that distinction.
Don't pick either yet if…
- You have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Semaglutide is contraindicated.
- You have a history of pancreatitis, severe gastroparesis, or significant kidney disease. Talk to a specialist first.
- You are pregnant, breastfeeding, or planning to become pregnant. GLP-1 medications are not approved for use during pregnancy.
- You're taking insulin or sulfonylureas. Combining these with GLP-1s increases hypoglycemia risk. A doctor needs to coordinate. See our GLP-1 eligibility guide.
These aren't suggestions — they're safety boundaries based on FDA prescribing information for semaglutide.
“MEDVi vs Ozempic” Isn't Really a Fair Comparison — Here's What You're Actually Choosing
Most articles on this topic get something fundamentally wrong. They compare MEDVi and Ozempic as if they're two brands of the same thing, like Coke vs Pepsi. They're not. Understanding the real distinction will save you confusion and help you make a smarter decision.
What Ozempic actually is
Ozempic is a brand-name medication made by Novo Nordisk, one of the largest pharmaceutical companies in the world. It contains semaglutide and is delivered as a weekly injection using a pre-filled pen.
Here's the part most people miss: Ozempic is FDA-approved for type 2 diabetes, not weight loss. The weight loss version of semaglutide from Novo Nordisk is called Wegovy, which has its own FDA approval for chronic weight management. When doctors prescribe Ozempic for weight loss, that's technically “off-label” use — perfectly legal, but insurance almost never covers it for that purpose. For more on the distinction, see our semaglutide vs tirzepatide comparison.
What MEDVi actually is
MEDVi is not a medication brand. It's a telehealth platform — a program that connects you with licensed physicians who can prescribe GLP-1 medications and ship them to your door.
Most MEDVi patients receive compounded GLP-1 medications. These are prepared by U.S. licensed compounding pharmacies — not by Novo Nordisk. Compounded medications are not FDA-approved as finished products. MEDVi also offers compounded tirzepatide. As of March 2026, MEDVi's product pages also list separate branded medication paths — Wegovy pill, Wegovy injection, and Zepbound injection — accessible via a $99/month membership plus medication cost. Verify current options at medvi.org before enrolling. MEDVi was founded in 2023 and is headquartered in Newark, Delaware, with operations in San Diego, California. It partners with OpenLoop Health for its physician network and is LegitScript certified.
*Illustration only. Actual medication packaging and appearance may vary.*
The real choice you're making
Option A: Brand-name semaglutide (Ozempic/Wegovy) from Novo Nordisk, FDA-approved as a finished product, available through traditional doctor visits and pharmacies, covered by insurance in some cases, costing $349–$499/month through Novo Nordisk's self-pay program or more at retail.
Option B: Physician-supervised compounded GLP-1 medication through a telehealth program (MEDVi), prepared by a licensed compounding pharmacy, not FDA-approved as a finished product, available without insurance for $179–$299/month.
Neither option is “better” in absolute terms. The right one depends on your insurance situation, your budget, your comfort level with compounded medications, and your access to in-person care. For more options, see our best GLP-1 online programs guide.
Is MEDVi's Medication “the Same Thing” as Ozempic?
This is the question behind the question. Let's be precise — and honest about what we can and can't say in 2026.
Ozempic contains semaglutide, manufactured by Novo Nordisk and FDA-approved as a finished product. MEDVi's compounded GLP-1 medications are prepared by licensed compounding pharmacies. However, compounded medications are not FDA-approved, and the FDA has warned that they cannot verify the quality, safety, or efficacy of compounded GLP-1 products.
Important FDA context (February 2026): On February 6, 2026, the FDA announced its intent to take action against non-FDA-approved GLP-1 drugs being mass-marketed as alternatives to approved products. The FDA stated that companies “cannot claim that non-FDA-approved compounded products are generic versions or the same as drugs approved by FDA” and that they “cannot state compounded drugs use the same active ingredient as the FDA-approved drugs or that compounded drugs are clinically proven to produce results for the patient.”
What “compounded” means in practice: Compounding pharmacies have existed in American medicine for decades. They prepare customized medications under state licensing. The FDA regulates compounding under the 503A and 503B frameworks, but has also stated that semaglutide injection products are no longer in shortage — which narrows the legal basis for compounding copies of commercially available semaglutide. For a deeper dive, see our guide on whether compounded semaglutide is safe.
The honest answer: Ozempic is an FDA-approved finished product with extensive clinical trial data behind that specific product. MEDVi's compounded medications are a different product with a different regulatory status. The clinical trial data (STEP 1, SELECT, etc.) was generated using FDA-approved semaglutide — not compounded versions. If you're considering a compounded GLP-1, verify the prescriber's credentials, the pharmacy's license, and read the FDA's current safety alerts about compounded GLP-1 products before making your decision.
Weight Loss Results: What the Clinical Data Actually Shows
Let's separate clinical trial data from marketing claims. You deserve to know the difference.
What peer-reviewed research shows about semaglutide
STEP 1 Trial (NEJM, Feb 2021): 1,961 adults with obesity. Semaglutide 2.4mg group lost an average of 14.9% of body weight at 68 weeks. 86% lost ≥5%. 69% lost ≥10%. 50% lost ≥15%.
STEP 5 Trial (Nature Medicine, Oct 2022): Weight loss with semaglutide was sustained over 104 weeks (2 full years).
SELECT Trial (NEJM, Nov 2023; Nature Medicine, 2024): 17,604 adults with cardiovascular disease and obesity. Semaglutide 2.4mg reduced major cardiovascular events by 20% (NEJM 2023). A subsequent Nature Medicine analysis reported ~10.2% mean weight loss sustained over 4 years (208 weeks).
STEP UP Trial (Novo Nordisk, Jan 2025): Higher dose semaglutide (7.2mg) achieved 20.7% average weight loss at 72 weeks. 33% of patients lost >25% of starting weight.
Real-world data (JAMA Network Open, Sep 2022): 175 patients in regular clinical practice — 5.9% weight loss at 3 months, 10.9% at 6 months.
*Illustration only. Clinical data from peer-reviewed sources cited in our sources section.*
What MEDVi reports about its patients
MEDVi states that patients in their program lose an average of 15–20% of their body weight, and that 93% keep the weight off with ongoing treatment. These are provider-stated figures. They have not been independently verified through a peer-reviewed clinical trial.
To be transparent: these numbers are plausible given the clinical data above, but we label them “provider-stated” because they haven't gone through the same level of scientific scrutiny as the STEP trials. For more context, see our GLP-1s for weight loss overview.
What real MEDVi patients are saying
From verified reviews on ConsumerAffairs (January 2026):
“MEDVi has been wonderful as a support system and medication provider. I've lost 25 pounds and feel amazing! The online support is convenient and the providers are mindful of the struggles associated with weight loss and medications.”
“I have been using the Semaglutide medication — I have lost 26 pounds in 6½ months! I feel so much better!”
“MEDVi has been incredible to work with. They are always available to provide support and answer questions. They have listened to my concerns and made adjustments to my medication that makes sense.”
The practical takeaway
What actually determines your results more than which brand you use: dose titration, side effect management, and consistency. Most people don't fail on GLP-1s because the medication doesn't work. They fail because nausea knocks them off track, they can't afford to keep going, or they don't have support. This is where a structured program can genuinely matter. If you're worried about side effects, try our GLP-1 side effect tool.
Side Effects and Safety: What You Need to Know Before Starting
Common side effects (most resolve within 2–4 weeks)
Nausea is the most frequently reported side effect, especially during the first few weeks and after dose increases. Other common side effects include vomiting, diarrhea, constipation, and stomach pain. In clinical trials, these were mild to moderate for most patients and decreased over time.
MEDVi addresses this proactively with gradual dose titration and 24/7 messaging so you can contact your provider at any hour. If you need anti-nausea medication, your provider can prescribe it separately (note: anti-nausea meds are not included in the MEDVi subscription). For food-specific tips, see our GLP-1 nausea food guide.
*Illustration only. Always consult your healthcare provider about side effects.*
Serious but rare warnings (from FDA prescribing information)
Thyroid C-cell tumors: In rodent studies, semaglutide caused thyroid C-cell tumors. Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2 syndrome.
Pancreatitis: Cases have been reported. Symptoms include severe abdominal pain that doesn't go away, sometimes radiating to the back.
Gallbladder problems: Associated with gallstones and gallbladder inflammation, particularly with rapid weight loss.
Kidney injury: Primarily associated with dehydration from severe nausea, vomiting, or diarrhea. Staying hydrated is critical.
Diabetic retinopathy: In patients with type 2 diabetes, rapid blood sugar improvement can temporarily worsen diabetic eye disease.
When to seek immediate medical attention
Contact your provider or go to the emergency room if you experience: severe abdominal pain that doesn't resolve, signs of an allergic reaction (swelling of face, lips, tongue; difficulty breathing; severe rash), symptoms of pancreatitis, or any sign of thyroid tumors (lump in neck, trouble swallowing, persistent hoarseness).
The SELECT trial tracked over 17,600 patients for four years and found that serious adverse events were actually lower in the semaglutide group than in the placebo group. For most people, the most significant side effect is temporary nausea that resolves within the first few weeks. To learn more, explore what happens when you stop taking GLP-1.
The Biggest Trust Question: Is Compounded Semaglutide Safe?
This is the section most “MEDVi vs Ozempic” articles either skip entirely or handle superficially. We're going to give it the attention it deserves, because your safety matters more than a sale.
What the FDA actually says
The FDA has issued increasingly strong warnings about compounded GLP-1 products. As of February 2026, their concerns include:
- Mass-marketing of compounded GLP-1s as alternatives to FDA-approved drugs
- Misleading claims that compounded products are “generic,” “the same as,” or “clinically proven”
- Semaglutide salt forms used by some compounders that may differ from approved products
- Counterfeit products sold without proper pharmacy credentials
- Dosing errors and improperly stored shipments arriving warm
MEDVi's safety infrastructure
Belmar Pharma Solutions — an established, state-licensed compounding pharmacy with a decades-long track record
Beluga Health — a telehealth platform that coordinates virtual care delivery
OpenLoop Health — a nationwide network of licensed medical providers
LegitScript certified — regularly monitored for compliance with applicable laws
The honest nuance
Compounded GLP-1 medications from licensed pharmacies are a different product than FDA-approved Ozempic or Wegovy. The finished compounded product hasn't undergone the same FDA review process. This is standard for all compounded medications — not a red flag specific to MEDVi — but it means you should verify every aspect of your provider and pharmacy. MEDVi's partnership with Belmar Pharma Solutions is meaningful — Belmar is one of the most well-known compounding pharmacies in the United States. For more context, read our best compounded semaglutide providers guide.
Your safety checklist before starting any GLP-1 program
1.Is the prescriber licensed? MEDVi uses licensed physicians through OpenLoop Health. Verify through your state medical board.
2.Is the pharmacy licensed? Belmar Pharma Solutions is state-licensed. Verify through your state board of pharmacy.
3.Does the medication arrive properly shipped? Temperature-controlled packaging is essential.
4.Is there real medical oversight? You should have access to a physician who reviews your health history and monitors your progress.
5.Can you verify what you received? Your medication should have clear labeling showing compound, concentration, pharmacy, and lot number.
MEDVi checks all five of these boxes. That's the baseline you should demand from any provider.
Cost Breakdown: What You'll Actually Pay (No Surprises)
Let's put real numbers on the table. For a full market-wide comparison, see our cheapest semaglutide guide and cheapest GLP-1 without insurance.
MEDVi compounded semaglutide pricing (re-checked March 30, 2026)
| Medication | First Month | Monthly Refills | Annual Cost (Year 1) |
|---|---|---|---|
| Compounded semaglutide injections | $179 | $299 | ~$3,468 |
| Compounded semaglutide tablets | $249 | $369 | ~$4,308 |
| Compounded tirzepatide injections | $279–$349 | $399 | ~$4,668–$4,738 |
| Compounded tirzepatide tablets | $279 | $399 | ~$4,668 |
| Brand-name Ozempic (limited supply) | $1,999 | $1,999 | ~$23,988 |
What's included in every MEDVi plan: Physician consultation, personalized treatment plan, prescription medication, unlimited 24/7 provider messaging, dose adjustments, metabolic report, and free shipping. No hidden fees. No insurance needed. No contract.
Ozempic pricing (re-checked March 30, 2026)
| Scenario | Monthly Cost | Notes |
|---|---|---|
| NovoCare intro offer | $199/mo for first 2 months | 0.25mg and 0.5mg only. Through June 30, 2026. |
| NovoCare self-pay (0.25–1mg) | $349/mo | After intro period |
| NovoCare self-pay (2mg) | $499/mo | Higher dose |
| List/WAC price | ~$1,027.51 per 28-day supply | Novo Nordisk list price (before insurance or discounts) |
| Retail pharmacy (no program) | Varies by pharmacy | Cash price varies by pharmacy, location, and available discounts |
| With commercial insurance (diabetes) | As low as $25 copay | Savings card applies up to $100/mo |
What's NOT included with Ozempic: Doctor visit fees, lab work, prior authorization effort, and follow-up appointments are all separate costs.
The real 12-month comparison
For the most common scenario — a person without diabetes seeking weight loss, paying out of pocket:
- MEDVi (semaglutide injections): ~$3,468 for year one. Medication, consultation, support, and shipping included.
- Ozempic via NovoCare (self-pay): $349–$499/month (~$4,188–$5,988/year at standard rates, plus doctor visits and labs). If the current $199 introductory offer applies to your first 2 fills, subtract about $300 from your first-year total.
- Ozempic at retail (no program): ~$12,330/year based on $1,027.51 list price, though actual cash prices vary by pharmacy.
The pricing detail you need to know: MEDVi's first month is $179 for injections. Refills are $299/month. A few patients have reported being surprised by the increase. The refill price is listed on MEDVi's pricing page and FAQ — you'll see it before checkout. Even at $299/month, MEDVi is still less expensive than Ozempic's NovoCare self-pay price of $349–$499.
How MEDVi Works: From Signup to Medication at Your Door
The entire process is designed to remove the friction that stops people from getting treatment.
Online evaluation (10–15 minutes)
Comprehensive health questionnaire covering medical history, current medications, weight-loss goals, and relevant conditions.
Physician review (within 24 hours)
A U.S.-licensed clinician from the OpenLoop Health network reviews your evaluation and determines whether GLP-1 therapy is appropriate. Not everyone is approved.
Choose your medication
Semaglutide or tirzepatide, injection or tablet. Your provider confirms the choice and sets your starting dose.
Medication ships to your door (5–9 business days)
Prescription filled by partner pharmacy and shipped in discreet, temperature-controlled packaging.
Start treatment with 24/7 support
Begin your prescribed regimen and access unlimited messaging support for dosing, side effects, or anything else.
Monthly renewal
Your membership renews every 28 days. Complete a refill form to coordinate your next medication shipment. Cancel at least 72 hours before renewal — no contract, no cancellation fee.
Lab work note: MEDVi doesn't require labs upfront for most patients, which speeds up the process. However, labs become mandatory after your third month to continue prescriptions. MEDVi covers lab costs at no extra charge. If you have a history of thyroid issues, pancreatitis, kidney or liver disease, or diabetes, labs may be required sooner.
Is MEDVi Legit? (The Trust Checklist)
We get why you're asking. The internet is full of sketchy GLP-1 sellers, and $179/month sounds too good to be true when brand-name Ozempic runs $349–$1,000+ depending on the program. So let's run through the trust signals.
LegitScript certified. Third-party verification used by Google, Facebook, and major platforms to identify legitimate healthcare businesses.
500,000+ patients served (MEDVi-stated). That suggests a scaled operation with established systems, though this figure is provider-stated.
4.4 TrustScore on Trustpilot from 11,498 reviews (as of March 30, 2026). Extremely high at that volume. MEDVi has replied to 98% of negative reviews.
Verified positive reviews on ConsumerAffairs (3.6/5, 1,597 reviews as of Mar 18, 2026). Reviews consistently praise responsive support, real weight loss results, and clear communication.
Licensed pharmacy and provider partners. Multiple U.S.-certified pharmacy partners (Belmar Pharma Solutions identified in third-party reports) and the OpenLoop Health physician network.
Published refund policy. Refund available if medically disqualified. Ordinary cancellation does not trigger a refund per current published terms. Review terms before purchasing.
Important: MEDVi is a separate company from MEDvidi, a mental health platform. Some reviews online confuse the two. Make sure you're reading about the right company.
The honest caveat
MEDVi isn't perfect. Some patients report shipping delays, especially during high-demand periods. A few mention confusion about billing cycles — specifically, MEDVi's billing starts from your signup date, not from when you receive your medication. These are real and valid complaints.
But here's the context: these are growing pains of a fast-scaling telehealth company, not signs of a scam. A 4.4-star TrustScore from 11,498 reviews means the overwhelming majority have a positive experience. No provider is flawless. The question is whether they deliver on the core promise. For another comparison perspective, see our MEDVi vs Remedy Meds analysis.
Convenience: Day-to-Day Experience Compared
The MEDVi experience
Everything happens online. You sign up, get evaluated, receive your medication at home, and communicate with your provider through messaging. No office visits required (though you can request a telehealth video call at no extra charge). Refills arrive monthly. If you have a question at midnight, you message your provider and get a response.
The Ozempic experience
Getting Ozempic typically involves: scheduling an appointment with your doctor, waiting for that appointment (often weeks), getting the prescription, dealing with insurance prior authorization (which can take additional weeks and may be denied), going to a pharmacy, and repeating portions of this every month. If you need a dose adjustment, you schedule another appointment.
Support and monitoring
MEDVi provides 24/7 unlimited messaging support. Providers check in regularly and adjust your dose or medication as needed. With brand Ozempic, your support depends entirely on your individual doctor's availability and practice style.
What to Expect Your First Month on MEDVi (Week by Week)
Week 1
You'll start at the lowest dose. Most people notice a subtle but real decrease in appetite within the first few days. Some experience mild nausea — this is normal. Eat smaller meals, stay hydrated, and don't push through large portions out of habit.
Week 2
Appetite suppression typically becomes more noticeable. You may find yourself forgetting to eat or feeling satisfied after half your normal portion. Some fatigue as your body adjusts to lower caloric intake. Protein intake matters — aim for at least 60–80 grams per day to preserve muscle mass.
Week 3
Initial side effects (if any) start fading. Cravings — especially for sugar and processed foods — often decrease significantly. This isn't willpower. It's the medication changing how your brain processes hunger signals.
Week 4
Most patients see their first measurable weight change. Clinical data suggests approximately 2–4% body weight loss in the first month at starting doses — roughly 4–8 pounds for someone starting at 200 lbs. Your provider will check in and discuss whether to increase your dose.
Months 2–6: The compounding effect
As your dose increases gradually, weight loss accelerates. By month 3, most patients are consistently losing 1–2+ pounds per week. By month 6, the average MEDVi patient has lost 15–20% of their starting body weight according to MEDVi's program data (provider-stated). That's 30–40 pounds for someone who started at 200 lbs.
Cancellation, Refunds, and Billing: Everything You Need to Know
How MEDVi billing works
- First month: You pay your introductory rate ($179 for injections, $249 for tablets, $279–$349 for tirzepatide injections, $279 for tirzepatide tablets) at checkout.
- Monthly refills: Complete a refill form and pay the refill rate ($299, $369, or $399 depending on medication).
- Billing cycle: Starts from your signup date, not from when you receive your medication. This catches some people off guard. Know your billing date.
- Auto-renewal: Your membership renews automatically every 28 days. You complete a refill form to coordinate your medication shipment, but billing is subscription-based — cancel at least 72 hours before your billing date to avoid the next charge.
How to cancel
No contract. No cancellation fee. MEDVi's membership auto-renews every 28 days. Your cancellation request must be received at least 72 hours before your billing date to avoid the next charge. Cancel via your MEDVi patient portal or in-app chat.
Refund and guarantee details
MEDVi's current published cancellation and refund policy: a refund is available if you are medically disqualified from the program. Ordinary cancellation of subscription services does not trigger a refund. The previously-advertised “5-month no-weight-loss” guarantee language does not appear in the current policy page. Always review MEDVi's current cancellation and refund policy before purchasing.
Protecting yourself
- Save your confirmation emails and receipts
- Note your billing date (it's your signup date)
- Screenshot pricing before checkout
- Contact support if anything is unclear before you refill
Ozempic vs Wegovy vs Compounded Semaglutide: What's the Difference?
People often use “Ozempic” as a catch-all for semaglutide, but there are actually three distinct paths:
Ozempic — Brand semaglutide by Novo Nordisk. FDA-approved for type 2 diabetes. Also approved for reducing cardiovascular risk. Doses approved (0.5mg, 1mg, 2mg) are lower than the weight-management dose. Frequently prescribed off-label for weight loss, but insurance typically won't cover it for that purpose.
Wegovy — Also brand semaglutide by Novo Nordisk, but specifically FDA-approved for chronic weight management at a higher dose (2.4mg). If your insurance covers a GLP-1 for weight loss, Wegovy is the one with that specific approval.
Compounded semaglutide (what MEDVi primarily prescribes) — Prepared by licensed compounding pharmacies. Not FDA-approved as a finished product. Available at significantly lower cost. This is the most common path for cash-pay patients seeking affordable GLP-1 access.
Alternatives People Cross-Shop (and Where MEDVi Fits)
MEDVi semaglutide vs tirzepatide
MEDVi offers both. Semaglutide targets GLP-1 receptors. Tirzepatide targets both GLP-1 and GIP receptors — a “dual agonist” approach that has shown higher average weight loss in head-to-head trials. If maximum weight loss is your priority, tirzepatide through MEDVi ($279–$349 first month injections depending on dose, $399 ongoing) may be worth discussing. Read more in our semaglutide vs tirzepatide guide.
MEDVi vs other telehealth GLP-1 providers
We've reviewed multiple GLP-1 telehealth providers. MEDVi stands out for competitive first-month pricing, 24/7 support, both injection and tablet options, no contract, nationwide availability (49 states), and LegitScript certification. For a full comparison, see our best GLP-1 providers guide. You may also want to read our MEDVi vs Remedy Meds comparison.
Our Methodology: How We Verified This Comparison
Pricing verification. All MEDVi pricing verified directly on medvi.org on March 30, 2026. All Ozempic pricing verified through ozempic.com and novocare.com on the same date. Prices may change — we verify monthly.
Clinical data. Every clinical claim cites peer-reviewed, published research. STEP 1 from NEJM (Feb 2021). STEP 5 from Nature Medicine (Oct 2022). SELECT from NEJM (Nov 2023). Real-world data from JAMA Network Open (Sep 2022). STEP UP from Novo Nordisk (Jan 2025).
Provider-stated vs verified. When MEDVi makes a claim (like “15–20% average weight loss”), we label it provider-stated. When a claim comes from peer-reviewed research, we cite the specific study.
Review verification. Patient testimonials are from ConsumerAffairs (verified reviews) and Trustpilot. We read hundreds of reviews and selected representative examples.
What we're not. We are not doctors. This page is informational, not medical advice. We are an independent review site that may earn a commission when you use our links. Read our full methodology and advertising disclosure.
Frequently Asked Questions
Is MEDVi the same as Ozempic?
No. Ozempic is a brand-name FDA-approved semaglutide medication made by Novo Nordisk. MEDVi is a telehealth program that primarily prescribes compounded GLP-1 medications that are not FDA-approved. These are different products with different regulatory pathways, even though they both involve semaglutide-based treatment under physician supervision.
How much does MEDVi cost per month?
MEDVi compounded semaglutide starts at $179 for the first month (injections) and $299 for monthly refills. Tablets start at $249 first month, $369 refills. Tirzepatide injections start at $279–$349 first month and $399 refills. MEDVi also offers a $99/month membership path for branded Wegovy pill, Wegovy injection, or Zepbound injection — you pay the membership fee plus the medication cost separately. All compounded plans include consultation, medication, 24/7 support, and free shipping.
Is MEDVi's compounded semaglutide FDA-approved?
No. The finished compounded product is not FDA-approved. This is standard for all compounded medications and is not unique to MEDVi. The FDA has warned that compounded GLP-1 products should not be marketed as equivalent to FDA-approved drugs.
Does MEDVi really work for weight loss?
Clinical trials conducted with FDA-approved semaglutide show an average of 14.9% body weight loss at 68 weeks (STEP 1, NEJM 2021). MEDVi reports that patients on its program lose 15–20% of body weight on average — these are provider-stated figures, not independently replicated in a peer-reviewed trial. That said, thousands of verified Trustpilot and ConsumerAffairs reviews do describe real, meaningful weight loss. Those trials used the FDA-approved drug; compounded versions have not been separately evaluated in peer-reviewed clinical studies.
Is MEDVi a scam?
No. MEDVi is LegitScript certified, holds a 4.4 TrustScore on Trustpilot from 11,498 reviews (verified March 30, 2026), and partners with licensed pharmacies and physicians. As with any compounded medication provider, verify the dispensing pharmacy’s license and read the FDA’s current guidance on compounded GLP-1 products before starting.
What are MEDVi's side effects?
The same as any semaglutide treatment: nausea (most common, usually temporary), vomiting, diarrhea, constipation, and stomach pain. These typically resolve within 2–4 weeks. Serious but rare side effects include pancreatitis, gallbladder issues, and kidney injury from dehydration. MEDVi includes 24/7 provider access to help manage side effects.
Can I get actual brand-name Ozempic through MEDVi?
MEDVi’s current product pages list separate paths for branded Wegovy pill, Wegovy injection, and Zepbound injection — accessed via a $99/month membership plus the medication cost. Compounded semaglutide (starting at $179/month) and compounded tirzepatide remain the most common paths for cash-pay patients. Verify current medication availability directly on medvi.org before enrolling.
How fast does MEDVi ship?
Most patients receive their medication within 5–9 business days after physician approval. Some patients report faster delivery; occasional delays occur during high-demand periods.
Does MEDVi accept insurance?
No. MEDVi is a cash-pay program. No insurance is required or accepted. This is actually an advantage for many patients — no prior authorization delays, no denials, and no need for a diabetes diagnosis to access semaglutide.
Can I use my HSA or FSA to pay for MEDVi?
MEDVi is a medical weight loss program prescribed by licensed physicians, which may qualify for HSA/FSA reimbursement depending on your plan. Check with your benefits administrator. MEDVi can provide documentation of your medical treatment for reimbursement purposes.
Does MEDVi offer a money-back guarantee?
MEDVi’s current published cancellation and refund policy is stricter than older summaries suggested. A refund is available if you are medically disqualified from the program. Ordinary cancellation of your subscription services does not trigger a refund. The earlier "5-month no-weight-loss" guarantee language no longer appears in the current policy. Review the current terms at home.medvi.org/cancellation-and-refund-policy before purchasing.
What's the difference between Ozempic and Wegovy?
Both contain semaglutide and are manufactured by Novo Nordisk. Ozempic is FDA-approved for type 2 diabetes. Wegovy is FDA-approved for weight management at a higher dose (2.4mg). When Ozempic is used for weight loss, it’s “off-label.”
Is Ozempic a GLP-1?
Yes. Ozempic (semaglutide) is a GLP-1 receptor agonist — it mimics the GLP-1 hormone your body naturally produces to regulate appetite and blood sugar.
What medication is comparable to Ozempic?
Wegovy (same manufacturer, weight-loss indication), compounded semaglutide (lower cost), and tirzepatide/Zepbound (different dual-action GLP-1/GIP agonist with potentially higher weight loss).
Is Zepbound better than Ozempic for weight loss?
Zepbound (tirzepatide) has shown higher average weight loss in clinical trials — around 20–22% vs 14.9% for semaglutide 2.4mg. However, individual responses vary, and semaglutide has more long-term safety data. MEDVi offers compounded tirzepatide starting at $279–$349/month (injections, depending on dose) for patients interested in this option.
Can I switch from Ozempic to compounded semaglutide?
Yes, many patients do. MEDVi’s providers can help transition your treatment. Discuss your current dose and history during your evaluation so they can match your treatment plan appropriately.
What happens when you stop taking semaglutide?
Research shows that most people regain some weight after stopping GLP-1 medications, because the appetite-suppressing effects wear off. This is why MEDVi emphasizes ongoing treatment and lifestyle habits. Your provider can help plan a maintenance strategy.
How long until I see weight loss?
Most people notice reduced appetite within days. Visible weight loss typically becomes noticeable at 4–8 weeks. In clinical trials, participants averaged about 6% body weight loss by week 12.
Who should NOT take GLP-1 medications?
People with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome. People with a history of pancreatitis. Those who are pregnant, breastfeeding, or planning pregnancy. People taking insulin or sulfonylureas (without physician coordination). Anyone with severe kidney disease or gastroparesis should consult a specialist first.
Can I drink alcohol on semaglutide?
There’s no absolute prohibition, but alcohol can worsen nausea (especially early in treatment) and may lower blood sugar. Most providers recommend moderation and being cautious, especially in the first few weeks.
What if I’m on insulin?
Talk to your endocrinologist before starting any GLP-1. Combining semaglutide with insulin or sulfonylureas increases hypoglycemia risk and requires dose coordination.
Is MEDVi available in my state?
MEDVi is available in 49 states. Check medvi.org for the most current state availability.
How do I cancel MEDVi?
MEDVi’s membership auto-renews every 28 days. To avoid the next charge, your cancellation request must be received at least 72 hours before your billing date. Cancel through your MEDVi patient portal, the in-app chat, or by contacting support. After cancellation, services continue through the end of your current billing cycle. Note that MEDVi’s published policy states that ordinary cancellation does not trigger a refund on subscription services already charged.
Is compounded semaglutide as effective as brand Ozempic?
Clinical trials were conducted with brand semaglutide, and compounded versions have not been independently tested as finished products. However, when properly prepared by a licensed compounding pharmacy, the medication is based on semaglutide — which is why MEDVi’s partnership with Belmar Pharma Solutions (a well-established compounder) matters.
What if I have side effects I can’t manage?
MEDVi provides 24/7 messaging support. Your provider can adjust your dose, switch your medication format, prescribe anti-nausea medication, or slow your titration schedule. You’re not managing this alone — that’s the entire point of a medically supervised program.
How does MEDVi compare to Hims or Ro?
MEDVi focuses specifically on GLP-1 weight loss with competitive pricing ($179 first month), 24/7 support, both injection and tablet options, and no contract. Hims and Ro offer GLP-1 programs as part of broader platforms. Ro may be a better fit if you want brand-name medications billed to insurance. For cash-pay compounded GLP-1 access, MEDVi’s pricing and support model are among the most competitive.
What foods should I eat (or avoid) on semaglutide?
Focus on lean proteins (chicken, fish, eggs, Greek yogurt) to maintain muscle mass. Eat smaller, more frequent meals rather than large portions. Avoid greasy, fried, or very fatty foods — these worsen nausea significantly, especially early in treatment. Stay hydrated.
Do I need to exercise while taking semaglutide?
Exercise isn’t required for the medication to work, but it significantly improves outcomes. Resistance training is particularly valuable — it helps preserve lean muscle mass during weight loss. Even 20–30 minutes of walking most days makes a meaningful difference.
Can I take semaglutide if I’ve had weight loss surgery?
This depends on the type of surgery and your current health status. Some post-bariatric surgery patients have used GLP-1 medications successfully. However, altered anatomy from certain procedures can affect how medications are absorbed. Disclose your surgical history during your MEDVi evaluation.
How is compounded semaglutide stored?
Compounded semaglutide should be refrigerated (36–46°F). MEDVi ships with temperature-controlled packaging. Once received, store in your refrigerator — not the freezer. Follow the storage instructions included with your shipment.
The Weight Loss Landscape Is Changing — and Access Is the Biggest Barrier
Here's the uncomfortable truth about GLP-1 medications in 2026: the science works, but most people can't access it.
Brand-name semaglutide costs over $1,000/month. Insurance coverage is limited, inconsistent, and often requires a diabetes diagnosis. Prior authorizations take weeks. Pharmacies face shortages. Doctors' offices have months-long waitlists. This isn't a drug problem. It's an access problem. For guidance navigating this, read our how to get GLP-1 without insurance guide.
Platforms like MEDVi exist because the traditional healthcare system created a gap between what's medically available and what most people can actually afford. Compounded GLP-1 medications through licensed pharmacies represent one pathway — though it's important to understand this is a different product with a different regulatory status than FDA-approved medications.
Your 5-Step Decision (Stop Overthinking, Start Deciding)
1.Decide: Do you need brand Ozempic specifically? If you have type 2 diabetes with insurance coverage, or you require an FDA-approved finished product — go with your doctor and brand Ozempic/Wegovy.
2.Decide: Are you comfortable with compounded semaglutide? After reading this page, you understand what compounded means, how it's regulated, and why MEDVi's pharmacy partnerships matter.
3.Calculate your real cost. Brand Ozempic without insurance: ~$4,200–$6,000/year via NovoCare self-pay, or $10,000+ at retail without a discount program. MEDVi semaglutide: ~$3,500/year. The savings are significant.
4.Verify. Check MEDVi's LegitScript certification. Read Trustpilot reviews. Look at ConsumerAffairs. Confirm current pricing on medvi.org.
5.Take the first step. Complete the online medical intake (10–15 minutes). You'll see exact pricing and terms before purchase. A U.S.-licensed clinician reviews your information to determine eligibility.
Final Verdict
MEDVi and Ozempic are not the same product. Ozempic is a brand-name medication that is the gold standard when insurance covers it. MEDVi is a telehealth program that makes physician-supervised GLP-1 treatment accessible to people who can't afford brand-name medications at retail prices, or who don't have insurance coverage for weight loss drugs.
- If you have insurance that covers Ozempic or Wegovy — use it.
- If you're paying cash and want FDA-approved medication — Novo Nordisk's NovoCare program starts at $349/mo.
- If you want a lower-cost, physician-supervised GLP-1 program — MEDVi starts at $179/mo with medication, consultation, and support included.
4.4 Trustpilot score from 11,498 reviews. LegitScript certified. Review current pricing and refund terms before purchase.
The best GLP-1 medication is the one you can afford, access, and stick with. For most people reading this page, that's MEDVi.
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication. Weight Loss Provider Guide is an independent review site. We may earn a commission from purchases through our links, which helps fund our research. Read our editorial standards and medical reviewer information.
Full medical disclaimer · Advertising disclosure · Learn more about GLP-1s
Sources
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183
- Garvey WT, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 2022;28(10):2083-2091.
- Lincoff AM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023. doi:10.1056/NEJMoa2307563
- Ryan DH, et al. Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial. Nature Medicine. 2024.
- Ghusn W, et al. Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity. JAMA Network Open. 2022;5(9):e2231982.
- Novo Nordisk A/S. Semaglutide 7.2 mg achieved 20.7% weight loss in STEP UP obesity trial. Press release. January 17, 2025.
- Ozempic (semaglutide) prescribing information. FDA AccessData. 2025. accessdata.fda.gov
- Wegovy (semaglutide) prescribing information. FDA AccessData. 2025. accessdata.fda.gov
- FDA. Concerns about unapproved GLP-1 drugs used for weight loss. fda.gov. Accessed March 2026.
- MEDVi official website. Pricing, policies, and program details. medvi.org and glp.medvi.org. Verified March 30, 2026.
- MEDVi cancellation and refund policy. home.medvi.org/cancellation-and-refund-policy. Verified March 30, 2026.
- Novo Nordisk. Ozempic and NovoCare pricing programs. ozempic.com, novocare.com. Verified March 30, 2026.
- ConsumerAffairs. MEDVi reviews. consumeraffairs.com. 1,597 reviews, 3.6/5 as of March 18, 2026.
- Trustpilot. MEDVi reviews. trustpilot.com/review/medvi.org. 11,498 reviews, 4.4 TrustScore as of March 30, 2026.
- Zepbound (tirzepatide) prescribing information. FDA AccessData. 2026. accessdata.fda.gov
Last updated: March 30, 2026. This page is reviewed and verified monthly. Pricing, policies, and availability are subject to change. Check medvi.org and ozempic.com for the most current information.